ARCHIVES

EntreMed Issued U.S. Patent For Active Parts Of Endostatin.

This article is from The Cancer Letter archive.

Vol. 27 No. 09 | March 2, 2001

Download PDF Visit The Full Archive

Related Articles

ONCC Says 1,480 Nurses Passed Certification Exam

January 6, 1989

NCI Objections Delay GAO Report On Cancer Control

March 7, 1980

Breast-Conserving Procedures Lead To Frequent Follow-up Care

April 27, 2012

Long-Term Results Of STAR Find Raloxifene Causes Fewer, Less Severe Side Effects

April 30, 2010

Vince DeVita: Startup Funds For New Clinical Research Difficult To Get; Many Private Physicians More Capable Of Caring For Cancer Patients Than Those In Centers

July 16, 1976

Greenwald Says NCI Still Committed To Year 2000 Goals

January 11, 1991